ARTBIO
About:
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Website: https://artbio.com
Twitter/X: artbio_inc
Top Investors: F-Prime Capital, Third Rock Ventures, Omega Funds
Description:
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.
$113M
$1M to $10M
Cambridge, Massachusetts, United States
2021-01-01
info(AT)artbio.com
Emanuele Ostuni, Roy H. Larsen, Øyvind Sverre Bruland
11-50
2023-12-07
Private
© 2025 bioDAO.ai